PROPLAZ Trademark

Trademark Overview

On Monday, June 17, 2013, a trademark application was filed for PROPLAZ with the United States Patent and Trademark Office. The USPTO has given the PROPLAZ trademark a serial number of 85961804. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 14, 2025. This trademark is owned by BioRich Medical, Inc.. The PROPLAZ trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, blood plasma concentration systems designed to concentrate platelet poor plasma
proplaz

General Information

Serial Number85961804
Word MarkPROPLAZ
Filing DateMonday, June 17, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 14, 2025
Registration Number4598452
Registration DateTuesday, September 2, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2013

Trademark Statements

Goods and ServicesMedical devices, namely, blood plasma concentration systems designed to concentrate platelet poor plasma

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 14, 2025
Primary Code010
First Use Anywhere DateWednesday, June 5, 2013
First Use In Commerce DateWednesday, June 5, 2013

Trademark Owner History

Party NameBioRich Medical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614
Party NameBioRich Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameBioRich Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92658

Trademark Events

Event DateEvent Description
Wednesday, June 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 20, 2013NEW APPLICATION ENTERED
Wednesday, September 25, 2013ASSIGNED TO EXAMINER
Wednesday, September 25, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2013PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 18, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 31, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 27, 2014TEAS STATEMENT OF USE RECEIVED
Friday, June 27, 2014USE AMENDMENT FILED
Sunday, July 20, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 30, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 31, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 2, 2014REGISTERED-PRINCIPAL REGISTER
Monday, September 2, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 1, 2021TEAS SECTION 8 & 15 RECEIVED
Saturday, July 10, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 10, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, July 10, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, September 2, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, March 14, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

proplaz plasma designed concentrate platelet poor systems concentration devices namely blood